98%
921
2 minutes
20
Infertility is a significant global challenge, affecting approximately 15% of couples. Premature Ovarian Failure (POF) is one of the primary causes of female infertility. Some new evidence suggests that gut microbiota influences ovarian function. This study investigated the therapeutic effects of probiotics, prebiotics, and synbiotics on POF. In the present experimental animal study, thirty Wistar rats were randomly divided into five groups: (1) Control group, (2) POF group (cisplatin-induced model), (3) POF-Probiotic group (daily gavage of Saccharomyces boulardii at 1 × 10⁹ CFU), (4) POF-Prebiotic group (daily gavage of inulin at 500 mg/kg), and (5) POF-Synbiotic group (a combination of prebiotic and probiotic). After 28 days, the animals were sacrificed, blood samples were collected, and the ovaries were removed for histological assessment, oxidative stress evaluation, and RT-PCR analysis. In all. Treatment groups in body weight, ovarian tissue index, and folliculogenesis were better than the POF group. Oxidative stress was significantly lower in the synbiotic-treated group compared to other treatments and POF groups. Moreover, synbiotic treatment enhanced the expression of genes involved in folliculogenesis and inhibited apoptosis-related gene expression compared to the POF group. Synbiotic supplementation effectively reduced oxidative stress and ovarian apoptosis while promoting folliculogenesis via upregulation of key genes involved in this process. Consequently, synbiotics may mitigate some of the adverse effects of POF and improve ovarian function in affected rats.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s12602-025-10696-y | DOI Listing |
J Turk Ger Gynecol Assoc
September 2025
Department of Pathology, Ege University Hospital, İzmir, Türkiye.
Our objective is to present the laparoscopic management of a mature cystic teratoma originating from the fallopian tube and to discuss different surgical approaches. A 28-year-old nulliparous woman presented with right groin pain, and after the diagnostic evaluation, laparoscopic exploration was performed for diagnosis and treatment. Intraoperative findings revealed a 4-5 cm cyst protruding from the right tubal fimbrial ostium was identified, originating from the tubal cavity without ovarian connection.
View Article and Find Full Text PDFAsia Pac J Oncol Nurs
December 2025
Department of Prevention Management, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Objective: To identify and evaluate the methodological quality and psychometric properties of Patient-reported outcome measures (PROMs) for symptom assessment in patients with cancer undergoing immunotherapy.
Methods: A systematic search was performed in PubMed, Scopus, Cochrane Library, Web of Science, Embase, CINAHL, CNKI, WanFang, Vip, and SinoMed from their inception to February 10, 2025. Eligibility criteria required studies to focus on the development or validation of a PROM for symptom assessment in adult patients with cancer undergoing immunotherapy, and to report on at least one psychometric property.
NAR Cancer
September 2025
Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.
Treatment of patients with platinum-resistant ovarian cancer is a major clinical challenge. We found that high expression of a meiotic protein, Synaptonemal Complex Protein 2 (SYCP2), is associated with platinum resistance and tyrosine kinase ABL1 inhibitor sensitivity in ovarian cancer. We demonstrate that tyrosine kinase ABL1 inhibitors inhibit cancer cell proliferation more efficiently in ovarian cancer cell lines with SYCP2 overexpression.
View Article and Find Full Text PDFOncol Res
September 2025
Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, 610041, China.
Objectives: Ovarian cancer, a leading cause of gynecological malignancy-related mortality, is characterized by limited therapeutic options and a poor prognosis. Although pyrimethamine has emerged as a promising candidate demonstrating efficacy in treating various tumors, the precise mechanisms of its antitumor effects remain obscure. This study was specifically designed to investigate the mode of action underlying the antitumor effects of pyrimethamine in preclinical settings.
View Article and Find Full Text PDFBackground And Aims: The role of anti-Müllerian hormone (AMH), a potential marker of the hypothalamic-pituitary-ovarian axis, is not well established in adolescent females. Typical epidemiologic studies use secondary sexual characteristics or chronological age as predictors for AMH. Skeletal maturity, an indicator of bone development, however, has not been examined in association with AMH in adolescent females.
View Article and Find Full Text PDF